Evidence map›Paper›PMID 35960783›Full record

SynthesisPloS one2022

Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis.

Esther Krijnen-de Bruin, Willemijn Scholten, Anna Muntingh, Otto Maarsingh, Berno van Meijel, Annemieke van Straten, Neeltje Batelaan

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Esther Krijnen-de BruinPsychiatry, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam UMC, Amsterdam, The Netherlands.ORCID 0000-0003-0800-8130
Willemijn ScholtenPsychiatry, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam UMC, Amsterdam, The Netherlands.
Anna MuntinghPsychiatry, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam UMC, Amsterdam, The Netherlands.
Otto MaarsinghGeneral Practice & Elderly Care Medicine, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam UMC, Amsterdam, The Netherlands.
Berno van MeijelPsychiatry, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam UMC, Amsterdam, The Netherlands.
Annemieke van StratenClinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam UMC, Amsterdam, The Netherlands.
Neeltje BatelaanPsychiatry, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam UMC, Amsterdam, The Netherlands.
GGZ inGeest · NLAmsterdam University Medical Centers · NLParnassia Groep · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe aim of this review is to establish the effectiveness of psychological relapse prevention interventions, as stand-alone interventions and in combination with maintenance antidepressant treatment (M-ADM) or antidepressant medication (ADM) discontinuation for patients with remitted anxiety disorders or major depressive disorders (MDD).

methodsA systematic review and a meta-analysis were conducted. A literature search was conducted in PubMed, PsycINFO and Embase for randomised controlled trials (RCTs) comparing psychological relapse prevention interventions to treatment as usual (TAU), with the proportion of relapse/recurrence and/or time to relapse/recurrence as outcome measure.

resultsThirty-six RCTs were included. During a 24-month period, psychological interventions significantly reduced risk of relapse/recurrence for patients with remitted MDD (RR 0.76, 95% CI: 0.68-0.86, p<0.001). This effect persisted with longer follow-up periods, although these results were less robust. Also, psychological interventions combined with M-ADM significantly reduced relapse during a 24-month period (RR 0.76, 95% CI: 0.62-0.94, p = 0.010), but this effect was not significant for longer follow-up periods. No meta-analysis could be performed on relapse prevention in anxiety disorders, as only two studies focused on relapse prevention in anxiety disorders.

conclusionsIn patients with remitted MDD, psychological relapse prevention interventions substantially reduce risk of relapse/recurrence. It is recommended to offer these interventions to remitted MDD patients. Studies on anxiety disorders are needed. SYSTEMATIC REVIEW REGISTRATION NUMBER: PROSPERO 2018: CRD42018103142.

Indexed as

DepressionPsychotherapyAntidepressive AgentsAnxietyAnxiety DisordersChronic DiseaseHumansPsychosocial InterventionRecurrenceAntidepressive Agents

Identifiers

PMID35960783
PMCPMC9374222
OpenAlexW4290852047

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.